Department of Biochemistry, Faculty of Science, University of Dschang, Dschang, Cameroon.
PLoS One. 2011;6(8):e21762. doi: 10.1371/journal.pone.0021762. Epub 2011 Aug 19.
Natural products are well recognized as sources of drugs in several human ailments. In the present work, we carried out a preliminary screening of six natural compounds, xanthone V(1) (1); 2-acetylfuro-1,4-naphthoquinone (2); physcion (3); bisvismiaquinone (4); vismiaquinone (5); 1,8-dihydroxy-3-geranyloxy-6-methylanthraquinone (6) against MiaPaCa-2 pancreatic and CCRF-CEM leukemia cells and their multidrug-resistant subline, CEM/ADR5000. Compounds 1 and 2 were then tested in several other cancer cells and their possible mode of action were investigated.
METHODOLOGY/FINDINGS: The tested compounds were previously isolated from the Cameroonian medicinal plants Vismia laurentii (1, 3, 4, 5 and 6) and Newbouldia laevis (2). The preliminary cytotoxicity results allowed the selection of xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone, which were then tested on a panel of cancer cell lines. The study was also extended to the analysis of cell cycle distribution, apoptosis induction, caspase 3/7 activation and the anti-angiogenic properties of xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone. IC(50) values around or below 4 µg/ml were obtained on 64.29% and 78.57% of the tested cancer cell lines for xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone, respectively. The most sensitive cell lines (IC(50)<1 µg/ml) were breast MCF-7 (to xanthone V(1)), cervix HeLa and Caski (to xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone), leukemia PF-382 and melanoma colo-38 (to 2-acetylfuro-1,4-naphthoquinone). The two compounds showed respectively, 65.8% and 59.6% inhibition of the growth of blood capillaries on the chorioallantoic membrane of quail eggs in the anti-angiogenic assay. Upon treatment with two fold IC(50) and after 72 h, the two compounds induced cell cycle arrest in S-phase, and also significant apoptosis in CCRF-CEM leukemia cells. Caspase 3/7 was activated by xanthone V(1).
CONCLUSIONS/SIGNIFICANCE: The overall results of the present study provided evidence for the cytotoxicity of compounds xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone, and bring supportive data for future investigations that will lead to their use in cancer therapy.
天然产物是治疗多种人类疾病的药物的重要来源。在本工作中,我们对六种天然化合物进行了初步筛选,包括黄烷酮 V(1)(1)、2-乙酰基呋喃-1,4-萘醌(2)、大黄素(3)、双比斯米亚醌(4)、维斯米亚醌(5)、1,8-二羟基-3-香叶基-6-甲基蒽醌(6),以评估它们对 MiaPaCa-2 胰腺癌细胞和 CCRF-CEM 白血病细胞及其多药耐药亚系 CEM/ADR5000 的抑制作用。然后,我们对化合物 1 和 2 进行了在其他几种癌细胞中的测试,并对其可能的作用机制进行了研究。
方法/结果:测试的化合物先前从喀麦隆药用植物 Vismia laurentii(1、3、4、5 和 6)和 Newbouldia laevis(2)中分离得到。初步的细胞毒性结果允许选择黄烷酮 V(1)和 2-乙酰基呋喃-1,4-萘醌,然后对它们进行了一系列癌细胞系的测试。研究还扩展到对黄烷酮 V(1)和 2-乙酰基呋喃-1,4-萘醌的细胞周期分布、凋亡诱导、半胱天冬酶 3/7 激活和抗血管生成特性的分析。黄烷酮 V(1)和 2-乙酰基呋喃-1,4-萘醌对 64.29%和 78.57%的测试癌细胞系的 IC(50)值分别约为或低于 4μg/ml。最敏感的细胞系(IC(50)<1μg/ml)是乳腺癌 MCF-7(对黄烷酮 V(1))、宫颈癌 HeLa 和 Caski(对黄烷酮 V(1)和 2-乙酰基呋喃-1,4-萘醌)、白血病 PF-382 和黑色素瘤 colo-38(对 2-乙酰基呋喃-1,4-萘醌)。两种化合物在鹌鹑卵的绒毛尿囊膜抗血管生成试验中分别抑制 65.8%和 59.6%的毛细血管生长。在两倍 IC(50)处理后 72 小时,两种化合物诱导 CCRF-CEM 白血病细胞的细胞周期停滞在 S 期,并显著诱导细胞凋亡。半胱天冬酶 3/7 被黄烷酮 V(1)激活。
结论/意义:本研究的总体结果为化合物黄烷酮 V(1)和 2-乙酰基呋喃-1,4-萘醌的细胞毒性提供了证据,并为进一步的研究提供了支持数据,这些研究将导致它们在癌症治疗中的应用。